{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:26Z","timestamp":1786993526898,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCI 2009-2011"],"award-info":[{"award-number":["NCI 2009-2011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001808","name":"Kommission f\u00fcr Technologie und Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018758","name":"Pediatric Transplantation and Cellular Therapy Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jtct.2022.01.021","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T17:27:10Z","timestamp":1643736430000},"page":"264.e1-264.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9372-5286","authenticated-orcid":false,"given":"Kirsten M.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-1215","authenticated-orcid":false,"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don E.","family":"Farthing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances T.","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beryl L.","family":"Manning-Geist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Gea-Banacloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leora E.","family":"Comis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1345-0257","authenticated-orcid":false,"given":"David G.","family":"Justus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Shing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8280-551X","authenticated-orcid":false,"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Gress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.01.021_bib0001","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.200212-1468OC","article-title":"Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation","volume":"168","author":"Chien","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2022.01.021_bib0002","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1083-8791(03)00242-8","article-title":"Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes","volume":"9","author":"Dudek","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0003","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.2009.1018","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation","volume":"302","author":"Williams","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2022.01.021_bib0004","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood-2016-08-693507","article-title":"How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"129","author":"Williams","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.021_bib0005","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1513\/pats.200601-007AW","article-title":"Mechanisms of airway obliteration after lung transplantation","volume":"3","author":"Nicod","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jtct.2022.01.021_bib0006","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00007890-200209270-00011","article-title":"Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome","volume":"74","author":"Palmer","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.01.021_bib0007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1378\/chest.128.1.153","article-title":"Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia","volume":"128","author":"Santo Tomas","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jtct.2022.01.021_bib0008","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.bmt.1704377","article-title":"Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation","volume":"33","author":"Marras","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0011","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1183\/09031936.95.08040551","article-title":"Post-transplant obstructive lung disease (\"bronchiolitis obliterans\"): a clinical comparative study of bone marrow and lung transplant patients","volume":"8","author":"Philit","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtct.2022.01.021_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1084\/jem.20042481","article-title":"BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation","volume":"202","author":"Medoff","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2022.01.021_bib0013","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI118612","article-title":"Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis","volume":"97","author":"Wilborn","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2022.01.021_bib0014","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4049\/jimmunol.175.2.713","article-title":"The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta- and gamma delta effector T cells","volume":"175","author":"Prinz","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.021_bib0015","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.4049\/jimmunol.173.10.6393","article-title":"A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung","volume":"173","author":"Okunishi","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.021_bib0016","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.tp.0000255575.03795.df","article-title":"Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study","volume":"83","author":"Or","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.01.021_bib0017","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbmt.2014.02.026","volume":"20","author":"Yanik","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0018","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/bmt.2011.1","article-title":"Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT\u2013a randomized double-blinded placebo-controlled study","volume":"46","author":"Lam","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0019","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2010.152","article-title":"Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT","volume":"46","author":"Lucid","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.bmt.1705026","article-title":"High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children","volume":"36","author":"Ratjen","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0021","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/bmt.2011.35","article-title":"Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD","volume":"46","author":"Hildebrandt","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0022","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/bmt.2009.33","article-title":"Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children","volume":"44","author":"Nishio","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0023","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1513\/AnnalsATS.201604-262OC","article-title":"Lung function trajectory in bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplant","volume":"13","author":"Cheng","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jtct.2022.01.021_bib0024","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbmt.2006.03.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report","volume":"12","author":"Martin","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general US population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2022.01.021_bib0026","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/bmt.2013.222","article-title":"NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT","volume":"49","author":"Williams","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0027","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bmt.1705434","article-title":"Quality of life associated with acute and chronic graft-versus-host disease","volume":"38","author":"Lee","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0028","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/bmt.2009.238","article-title":"Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)","volume":"45","author":"Mitchell","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0029","doi-asserted-by":"crossref","first-page":"368","DOI":"10.7326\/0003-4819-111-5-368","article-title":"Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course","volume":"111","author":"Clark","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2022.01.021_bib0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bmt.1700894","article-title":"Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation","volume":"20","author":"S\u00e1nchez","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1034\/j.1399-0012.1999.130201.x","article-title":"Bronchoalveolar lavage in lung transplantation. State of the art","volume":"13","author":"Tiroke","year":"1999","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0032","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/ppul.24801","article-title":"Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"55","author":"Walther","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jtct.2022.01.021_bib0033","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2004.11.014","article-title":"Characterization of within-subject responses to fluticasone and montelukast in childhood asthma","volume":"115","author":"Szefler","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2022.01.021_bib0034","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbmt.2015.10.009","article-title":"Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation","volume":"22","author":"Williams","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/COPD.S27480","article-title":"Lung function decline in COPD","volume":"7","author":"Tantucci","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jtct.2022.01.021_bib0036","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/ctr.12638","article-title":"Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Ahn","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0037","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s004280050099","article-title":"Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Nagoya BMT Group","volume":"431","author":"Yokoi","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtct.2022.01.021_bib0038","doi-asserted-by":"crossref","unstructured":"Duarte RF, Greinix H, Rabin B, et al. Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force. Bone Marrow Transplant. 2014;49:49-54.","DOI":"10.1038\/bmt.2013.129"},{"key":"10.1016\/j.jtct.2022.01.021_bib0039","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3349\/ymj.2016.57.2.365","article-title":"Risk factor and clinical outcome of bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Rhee","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jtct.2022.01.021_bib0040","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/bmt.2013.17","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight\u2014new perspectives?","volume":"48","author":"Ditschkowski","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0041","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/1529-0131(200108)44:8<1865::AID-ART325>3.0.CO;2-M","article-title":"Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis","volume":"44","author":"Kowal-Bielecka","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2022.01.021_bib0042","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1098-8823(03)00076-5","article-title":"Cysteinyl-leukotrienes and the liver","volume":"72","author":"Farzaneh-Far","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jtct.2022.01.021_bib0043","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1084\/jem.20170261","article-title":"Inhibition of 5-lipoxygenase alleviates graft-versus-host disease","volume":"214","author":"Rezende","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2022.01.021_bib0044","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1172\/JCI75935","article-title":"CSF-1-dependent donor-derived macrophages mediate chronic graft-versus-host disease","volume":"124","author":"Alexander","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2022.01.021_bib0045","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.bbmt.2007.06.009","article-title":"Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool","volume":"13","author":"Fukunaga","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.021_bib0046","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood-2005-06-2362","article-title":"The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans","volume":"107","author":"Islam","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.021_bib0047","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.2174\/092986706778742963","article-title":"Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities","volume":"13","author":"Capra","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jtct.2022.01.021_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193564","article-title":"Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a randomized controlled trial","volume":"13","author":"Ruttens","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2022.01.021_bib0049","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.healun.2018.11.014","article-title":"Montelukast in chronic lung allograft dysfunction after lung transplantation","volume":"38","author":"Vos","year":"2019","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:59:37Z","timestamp":1778921977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2666636722000495"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.01.021","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}